| [1] |
Kassis AI, Adelstein SJ, Mariani G. Radiolabeled nucleoside analog cancer diagnosis and therapy. J Nucl Med, 1996, 40(3):301-319.
|
| [2] |
孙晗笑, 陆大祥, 刘飞鹏, 等.转基因技术理论与应用.郑州:河南医科大学出版社,2000.346-364.
|
| [3] |
Sedelnikova OA, Panyutin IG, Thierry AR, et al. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalin cells. J Nucl Med, 1998, 39(8):1412-1418.
|
| [4] |
Panyutin IG, Neumann RD. Sequence-specific DNA breaks produced by triplex-directde decay of iodine-125. Acta Oncol,1996, 35(7):817-823.
|
| [5] |
Cammilleri S, Perdereau B, Brixy F, et al. Imaging and biodistribution of 125I tyramine oligonucleotide in nude mice bearing human breast tumor. Preliminary report. Bull Cancer Paris, 1996, 83(1):23-26.
|
| [6] |
刘生, 刘长征, 梁碧玲, 等.碘标记反义寡核苷酸的研究及其稳定性与生物分布的评价.核技术,2004,27(5):365-369.
|
| [7] |
Spitzweg C, Scholz IV, Bergert ER, et al. Retinoic acid induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells. Endaocrinology, 2003, 144(8):3423-3432.
|
| [8] |
Ou X, Tan T, He L, et al. Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor. Cancer Gene Ther, 2005, 12(3):313-320.
|